Contact
Please use this form to send email to PR contact of this press release:
ERYTECH Granted U.S. FDA Fast Track Designation for eryaspase in Second-Line Pancreatic Cancer
TO:
Please use this form to send email to PR contact of this press release:
ERYTECH Granted U.S. FDA Fast Track Designation for eryaspase in Second-Line Pancreatic Cancer
TO: